Tuberculosis Research Blood Bank

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00212498

Enrollment

Registered

2005-09-21

Start date

2006-11-30

Completion date

Unknown

Last updated

2015-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Brief summary

To create a Tuberculosis Research Blood Bank for future molecular genetics and serological studies

Interventions

PROCEDUREDevelop a bank of blood samples from patients infected with TB for future molecular genetics studies and serological studies

Blood sample

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

21 Years to 75 Years

Healthy volunteers

Inclusion criteria

* TB suspect with positive sputum smear

Design outcomes

Primary

Measure	Time frame	Description
Develop TB Blood Bank	Long-Term	To develop a bank of blood samples (serum, plasma, buffy coat DNA) and urine from patients infected with TB. This blood and urine will be used for future molecular genetics studies. Demographic data will be collected and samples will be stored by number. The banked specimens will be evaluated in an attempt to identify susceptibility genes in TB disease. Specifically, expression of the human Bcg gene that codes for resistance to M. tuberculosis will be evaluated and its expression correlated expression with gender, race, clinical TB characteristics. Each patient will have a unique identifier and therefore data generated from this analysis will not be linkable to the patient.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026